Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
4
×
detroit blog main
detroit top stories
glaxosmithkline
4
×
immunotherapy
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
clinical trials
gene therapy
gilead sciences
nonalcoholic steatohepatitis
startups
akcea therapeutics
alzheimer's disease
amgen
What
roundup
bio
drug
nash
news
abbvie’s
according
acquisitions
ahead
akcea
albert
approval
biggest
biofourmis
biogen’s
biopharmaceutical
biotech
bourla
bucks
cancer
cases
celebrate
centers
ceo
chance
cigarettes
companies
company
control
convo
corner
crispr
day
days
deaths
disease
earlier
electronic
failures
forward
Language
unset
unknown
Current search:
immunotherapy
×
glaxosmithkline
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More